579 related articles for article (PubMed ID: 10576759)
21. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.
Saito T; Endo T; Kawaguchi A; Ikeda M; Nakazato M; Kogai T; Onaya T
J Clin Endocrinol Metab; 1997 Oct; 82(10):3331-6. PubMed ID: 9329364
[TBL] [Abstract][Full Text] [Related]
22. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
23. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
24. Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene.
Suzuki K; Mori A; Saito J; Moriyama E; Ullianich L; Kohn LD
Endocrinology; 1999 Nov; 140(11):5422-30. PubMed ID: 10537174
[TBL] [Abstract][Full Text] [Related]
25. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.
Ryu KY; Senokozlieff ME; Smanik PA; Wong MG; Siperstein AE; Duh QY; Clark OH; Mazzaferri EL; Jhiang SM
Thyroid; 1999 Apr; 9(4):405-9. PubMed ID: 10319949
[TBL] [Abstract][Full Text] [Related]
26. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene.
Shimura H; Haraguchi K; Miyazaki A; Endo T; Onaya T
Endocrinology; 1997 Oct; 138(10):4493-6. PubMed ID: 9322970
[TBL] [Abstract][Full Text] [Related]
27. Iodide symporter gene expression in human thyroid tumors.
Arturi F; Russo D; Schlumberger M; du Villard JA; Caillou B; Vigneri P; Wicker R; Chiefari E; Suarez HG; Filetti S
J Clin Endocrinol Metab; 1998 Jul; 83(7):2493-6. PubMed ID: 9661633
[TBL] [Abstract][Full Text] [Related]
28. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
29. The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity.
Ajjan RA; Watson PF; Findlay C; Metcalfe RA; Crisp M; Ludgate M; Weetman AP
J Endocrinol; 1998 Sep; 158(3):351-8. PubMed ID: 9846164
[TBL] [Abstract][Full Text] [Related]
30. Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression.
Kogai T; Curcio F; Hyman S; Cornford EM; Brent GA; Hershman JM
J Endocrinol; 2000 Oct; 167(1):125-35. PubMed ID: 11018760
[TBL] [Abstract][Full Text] [Related]
31. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
Eng PH; Cardona GR; Fang SL; Previti M; Alex S; Carrasco N; Chin WW; Braverman LE
Endocrinology; 1999 Aug; 140(8):3404-10. PubMed ID: 10433193
[TBL] [Abstract][Full Text] [Related]
32. Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues.
Kollecker I; von Wasielewski R; Langner C; Müller JA; Spitzweg C; Kreipe H; Brabant G
Thyroid; 2012 May; 22(5):529-35. PubMed ID: 22545753
[TBL] [Abstract][Full Text] [Related]
33. Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas.
Russo D; Manole D; Arturi F; Suarez HG; Schlumberger M; Filetti S; Derwahl M
Thyroid; 2001 Jan; 11(1):37-9. PubMed ID: 11272095
[TBL] [Abstract][Full Text] [Related]
34. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
[TBL] [Abstract][Full Text] [Related]
35. Expression of the sodium iodide symporter in human kidney.
Spitzweg C; Dutton CM; Castro MR; Bergert ER; Goellner JR; Heufelder AE; Morris JC
Kidney Int; 2001 Mar; 59(3):1013-23. PubMed ID: 11231356
[TBL] [Abstract][Full Text] [Related]
36. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
[TBL] [Abstract][Full Text] [Related]
37. HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells.
Chai W; Ye F; Zeng L; Li Y; Yang L
J Exp Clin Cancer Res; 2019 Jul; 38(1):325. PubMed ID: 31331356
[TBL] [Abstract][Full Text] [Related]
38. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
[TBL] [Abstract][Full Text] [Related]
39. Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters.
Lacroix L; Pourcher T; Magnon C; Bellon N; Talbot M; Intaraphairot T; Caillou B; Schlumberger M; Bidart JM
J Clin Endocrinol Metab; 2004 Mar; 89(3):1423-8. PubMed ID: 15001644
[TBL] [Abstract][Full Text] [Related]
40. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]